SF 272 Minnesota Senate · 2019-2020 Regular Session

Price gouging by drug manufacturer or wholesale distributor prohibition; pharmacy board, human services commissioner and health plan companies notification of prescription drug price increases to the attorney general authorization; attorney general drug pricing information access and action against drug manufacturers and wholesalers authorization; civil penalties imposition

Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2019
Committee Review
Floor Vote
Governor
Introduced Jan 17, 2019 Last action Jan 28, 2019
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
1
Jan 17, 2019
Committee
Referred to Health and Human Services Finance and Policy
upper
Jan 17, 2019
Introduced
Introduction and first reading
upper
1 primary · 3 co-sponsors

Sponsors